Linezolid-induced thrombocytopenia in impaired renal function: is it time for a dose adjustment? A case report and review of literature (Q33410244)

26 July 2017

Linezolid-induced thrombocytopenia in impaired renal function: is it time for a dose adjustment? A case report and review of literature (English)

1 reference

26 July 2017

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24022332%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Paolo Mura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24022332%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Lorenzo M De Giudici

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24022332%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Gabriele Finco

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24022332%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

A P Cossu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24022332%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

language of work or name

1 reference

1 January 2014

1 reference

European Journal of Clinical Pharmacology

26 July 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24022332%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24022332%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24022332%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

23-28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24022332%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00228-013-1585-6

13 June 2020

exact match

0 references

cites work

Etiology and significance of thrombocytopenia in critically ill patients

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Antimicrobial drug-induced thrombocytopenia: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

No effect of pyridoxine on the incidence of myelosuppression during prolonged linezolid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Mechanisms for linezolid-induced anemia and thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Linezolid and reversible myelosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Population pharmacokinetic analysis of linezolid in patients with infectious disease: application to lower body weight and elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Pharmacokinetic studies of linezolid and teicoplanin in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Renal function as a predictor of linezolid-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Pharmacokinetics of linezolid in subjects with renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Pharmacokinetics of repeated dosing of linezolid in a hemodialysis patient with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Thrombocytopenia associated with linezolid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Influence of linezolid clearance on the induction of thrombocytopenia and reduction of hemoglobin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Correlation between serum linezolid concentration and the development of thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

A reduced linezolid dosage maintains favorable efficacy with minimal hematologic toxicity in a methicillin-resistant Staphylococcus aureus-infected patient with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Probable linezolid-induced thrombocytopenia in a patient with vancomycin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

Linezolid-associated thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1585-6